Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Global Cord Blood Corporation

Global Cord Blood Corporation (CO) Stock Overview

Explore Global Cord Blood Corporation’s financial performance, market position, analyst ratings, and future outlook.

CO●NYSE
HealthcareMedical - Diagnostics & Research
$2.99
$0.77(34.58%)
U.S. Market opens in 12h 46m

Global Cord Blood Corporation (CO)

Meyka AI Score

Z

Key Financials

Market Cap400.1M
P/E Ratio4.89
EPS (TTM)$0.59
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$2.78

CO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Global Cord Blood Corporation (NYSE: CO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Global Cord Blood Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CO on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $2.78 for the NYSE listing.

Key metrics behind Global Cord Blood Corporation's NYSE-traded stock include a P/E ratio of 4.89 and a market capitalization of 400.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CO on the NYSE.

Price Performance (NYSE: CO)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.08%
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
14.91%
3-Year Change
-9.19%
5-Year Change
-65.82%
All-Time (Max) Change
-45.14%

Contact Information

https://www.globalcordbloodcorp.com
852 3605 8180
Bank of China Tower, Central, NaN, NaN

Company Facts

12,020 Employees
IPO DateJan 25, 2007
CountryHK

Frequently Asked Questions